Perrigo Company plc, a leading global provider of consumer self-care products, announced that it has reached a definitive agreement to sell its Generic Rx Pharmaceuticals business to Altaris Capital Partners, LLC for total consideration of $1.55 billion, including $1.5 billion in cash, subject to customary adjustments. As part of the consideration, Altaris will also assume more than $50 million in potential R&D milestone payments and contingent purchase obligations with third-party Rx partners.
(Reuters) - Perrigo Company Plc on Monday posted quarterly earnings below estimates and said it would sell its underperforming generic drugs business for $1.55 billion, as the consumer healthcare products company sharpens focus on its core business.
DUBLIN and GRAND RAPIDS, Mich., Jan. 11, 2021 /PRNewswire/ -- Perrigo Company plc (NYSE; TASE: PRGO), a leading provider of Quality, Affordable Self-Care Products, announced today a formal partnership with Michigan State University (MSU), connecting the university's clinical and research expertise with Perrigo's product innovation, manufacturing scale and retail partnerships to empower consumers to take control of their self-care needs.
The Revenue Commissioners has disputed claims it had no entitlement to raise a €1.64 billion tax assessment against drug company Perrigo.
Shares of over-the-counter pharma products maker Perrigo Company plc (PRGO) dropped $8.62 or 14.27% on Thursday after its fourth-quarter earnings missed the consensus estimates. The stock closed the day's trade at $51.82 and has traded in the range of $40.68- $63.86 in the last year.
DUBLIN, Jan. 6, 2020 /PRNewswire/ -- Perrigo Company plc (NYSE; TASE: PRGO) announced today that its Ranir subsidiary has acquired the assets of Steripod®, a leading toothbrush accessory brand and innovator in the toothbrush protector market, from Bonfit America Inc. The deal includes the Steripod® portfolio of antibacterial toothbrush protectors, kids' products and tongue cleaners. Terms of the deal were not disclosed.
Strengthens Perrigo’s oral self-care leadership position with acquisition of the #1 and fastest growing value brand player in the children’s oral care category